2018 ISV Congress

isv vaccine congress 2018The ISV Annual Congress is the world’s largest scientific conference in the field of vaccines and covers a broad range of topics related to vaccines and immunotherapies. It will bring together individuals from all sectors of the global vaccine community to hear about the latest advances in the field, discuss challenges and opportunities, and network.

Keynote Address at the 2018 International Society for Vaccines (ISV)

  • Dr. Julie Gerberding

    julie gerberdingThe 2018 ISV Congress is pleased to announce the Opening Keynote Speaker as Dr. Julie Gerberding, M.D., M.P.H., Executive Vice President - Communications, Global Policy, and Population Health, and Chief Patient Officer at Merck.  Dr. Gerberding, was recently honored as the Healthcare Businesswomen's Association (HBA) 2018 Woman of the Year. Julie was recognized for her remarkable contributions to health as a physician, infectious disease expert, first female director of the CDC and for her leadership roles at Merck

  • Dr. Adel Mahmoud

    adel mahmoudJulie will present the Opening Keynote Lecture on Sunday morning, October 28th at the Congress in honor of Dr. Adel Mahmoud (24 August 1941 – 11 June 2018). Dr. Mahmoud was an infectious-disease expert who played a vital role in the development of lifesaving vaccines. He served as president of Merck Vaccines from 1998 until 2006, Dr. Mahmoud oversaw the creation and marketing of several vaccines that brought major advances in public health. These include a vaccine which prevents rotavirus infection (a potentially fatal cause of diarrhea in babies), a vaccine for HPV, combination vaccines (MMRV), among others. He was also a champion of global health issues and the need for new approaches to develop vaccines for emerging markets

2018 Confirmed Speakers

Rafi, Ahmed, USA
Rafi, Ahmed, USA
Martin Bachmann, UK
Martin Bachmann, UK
Hank Balfour, USA
Hank Balfour, USA
Edward Belongia, USA
Edward Belongia, USA
James Cherry, USA
James Cherry, USA
James Crowe, USA
James Crowe, USA
Tony Cunningham, Australia
T. Cunningham, Australia
Baptiste Dungu, Africa
Baptiste Dungu, Africa
Jean-Louis Excler, Korea
Jean-Louis Excler, Korea
Tong-Ming Fu, USA
Tong-Ming Fu, USA
Jonathan Gershoni, Israel
Jonathan Gershoni, Israel
Eun-Kyoung Jo, Korea
Eun-Kyoung Jo, Korea
Aidar Ishmukhametov, Russia
A. Ishmukhametov, Russia
Ravi Kane, USA
Ravi Kane, USA
Hiroshi Kiyono, Japan
Hiroshi Kiyono, Japan
Harry Kleanthous, USA
Harry Kleanthous, USA
Gary Kobinger, Canada
Gary Kobinger, Canada
Yong Taik Lim, Korea
Yong Taik Lim, Korea
Karin Loré, Sweden
Karin Loré, Sweden
Nils Lycke, Sweden
Nils Lycke, Sweden
Guanghui Ma, China
Guanghui Ma, China
Michael McNeil, USA
Michael McNeil, USA
Martin Moore, USA
Martin Moore, USA
Hironori Nakagami
Hironori Nakagami
Vish Nene, Kenya
Vish Nene, Kenya
Morten Nielsen, Denmark
Morten Nielsen, Denmark
Glen Nowak, USA
Glen Nowak, USA
John Oxford, UK
John Oxford, UK
Pauline Paterson, UK
Pauline Paterson, UK
Hyewon Phee, USA
Hyewon Phee, USA
Stanley Plotkin, USA
Stanley Plotkin, USA
Thomas L. Richie, USA
Thomas L. Richie, USA
Nadine Rouphael, USA
Nadine Rouphael, USA
Tim Schacker, USA
Tim Schacker, USA
Terry Tumpey, USA
Terry Tumpey, USA

2018 Scientific Committee

  • Ted Ross

    Ted Ross, ISV Congress co-Chair
    University of Georgia - USA

  • Denise Doolan

    Denise Doolan, ISV Congress co-Chair
    James Cook University - Australia

  • Rafi Ahmed, ISV local co-Chair
    Emory University - USA

  • Julie Hilliard, ISV local co-Chair
    Georgia State University - USA

  • Mark R. Prausnitz, ISV local co-Chair
    Georgia Tech University - USA

  • Randy Albrecht, Icahn School of Medicine at Mount Sinai, USA
  • Guirakhoo Farshad, Geo Vax, USA
  • Lars Frelin, Karolinska Institutet, Sweden
  • Davinder Gill, Hilleman Laboratories, India
  • Ali Harandi, University of Goteborg, Sweden
  • Stephen Hoffman, Sanaria, USA
  • Linda Klavinskis, King's College London, UK
  • Karl Ljungberg, Karolinska Institutet, Sweden
  • Janet McNicholl, Centers for Disease Control and Prevention, USA
  • Ed Mocarski, Emory University, USA
  • Marty Moore, Meissa Vaccines, USA
  • Mark R. Schleiss, University of Minnesota, USA
  • Sean Tucker, Vaxart, USA
  • Jeffrey Ulmer, GlaxoSmithKline, USA
  • Thiru Vanniasinkam, Charles Sturt University, Australia
  • Nene Vish, ILRI, Kenya
  • Heather Wilson, University of Saskatchewan, Canada
  • Anna-Lise Williamson, University of Cape Town, South Africa
  • Suh-Chin (Samuel) Wu, National Tsing Hua University, Taiwan

2018 Partners & Sponsors

  • Partners:
  • Bill & Melinda Gates Foundation
  • jsv
  • hvi
  • kvs
  • tav
  • Georgia Bio
  • jgv

Sponsors:

  • Diamond
  • VGXI
  • Platinum
  • Epivax
  • Inovio
  • pfizer
  • Gold
  • Georgia Research Alliance
  • gc pharma.png
  • Sanofi Pasteur
  • hivf
  • merck
  • Silver
  • Eurogentec
  • center for vaccine and immunology
  • indevr
  • mabtech
  • ctl
  • acea